Icon	Function
💬	A pop-up explanation appears when you mouse-over the text beside this icon. Also, an explanation window appears when you click this icon.
	The links beside this icon are links to external sites.
	Clicking this icon sorts the table by the item with this icon (Numerical or alphabetical order). Each click toggles between ascending and descending order.
	A text longer than 100 characters is fully displayed or collapsed.
	The contents of the displayed table are downloaded as a file named "table.csv".

DR info

Clinical trials : 55 / Drugs : 61 - (DrugBank : 17) / Drug target genes : 19 - Drug target pathways : 40

Drugs, Primary sponsors and Trial info (Enrollment year, Phase, Trial ID, Countries)

9060X
      2010   Phase 4   EUCTR2009-015620-29-BE   Belgium
Acellular nerve allograft
   The First Affiliated Hospital, Sun Yat-sen University
      2020   -   ChiCTR2500099694   China
Anakinra
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Anatomical landmark-guided suprascapular nerve block
   Abant Izzet Baysal University
      2022   Phase 4   NCT05260125   Turkey
Baclofen
   Mustafa Kemal University
      2018   Phase 4   NCT03860662   Turkey
Balance exercise
   Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University
      2020   -   JPRN-UMIN000042549   Japan
   Halic University
      2025   -   NCT07304180   Turkey (Türkiye)
   Otaka Yohei
      2019   -   JPRN-jRCTs042190020   -
Berg balance scale
   Uskudar State Hospital
      2023   -   NCT05871723   -
Blood flow restriction
   Yunhong Tian
      2023   -   NCT06461013   China
Blood flow restriction training
   Affiliated Hospital of North Sichuan Medical College
      2023   -   ChiCTR2500095271   China
   Cairo University
      2025   -   NCT07648550   Egypt
   The First Affiliated Hospital of Zhengzhou University
      2026   -   NCT07454954   -
Botox
      2010   Phase 4   EUCTR2009-015620-29-BE   Belgium
   Fatih Sultan Mehmet Training and Research Hospital
      2024   -   NCT07331844   Turkey (Türkiye)
   Mustafa Kemal University
      2018   Phase 4   NCT03860662   Turkey
Botulinum toxin
   Nanjing Sports Institude
      2014   -   ChiCTR-ICR-15007022   China
   University of Ioannina
      2020   Phase 1   NCT04630873   Greece
Botulinum toxin application
   Abant Izzet Baysal University
      2025   -   NCT07083752   Turkey (Türkiye)
Botulinum toxin type A
      2010   Phase 4   EUCTR2009-015620-29-BE   Belgium
   Fatih Sultan Mehmet Training and Research Hospital
      2024   -   NCT07331844   Turkey (Türkiye)
Brivaracetam
   UCB Japan Co., Ltd.
      2019   Phase 3   JPRN-jRCT2080224076   Japan
      2017   Phase 3   JPRN-jRCT2080223631   Asia except Japan;Japan
      2017   Phase 3   JPRN-jRCT2080223559   Asia except Japan;Japan
Child sensory profile 2 (SP2) FOR sensory processing abilities
   Cairo University
      2023   -   NCT06989034   Egypt
Conservative rehabilitation
   Abant Izzet Baysal University
      2021   -   NCT05552742   Turkey
Conventional rehabilitation
   Beijing Xiaotangshan Hospital
      2024   Phase 0   ChiCTR2400080358   China
   Changzhou De'an Hospital
      2026   -   ChiCTR2500115588   China
   The First Affiliated Hospital of Zhengzhou University
      2026   -   NCT07454954   -
   The First Affiliated Hospital, Sun Yat-sen University
      2020   -   ChiCTR2500099694   China
   Zhongda Hospital of Southeast University
      2024   -   ChiCTR2400080158   China
Edonerpic
   FUJIFILM Toyama Chemical Co., Ltd
      2019   Phase 2   JPRN-jRCT2080224564   Japan
Exergaming
   Halic University
      2025   -   NCT07304180   Turkey (Türkiye)
Ezetimibe
   Hengdian Wenrong Hospital
      2025   Phase 1   ChiCTR2500099188   China
Fenfluramine
   University Hospital Antwerp
      2011   Phase 3   EUCTR2011-004114-42-BE   Belgium
Gait analysis
   University of Ioannina
      2020   Phase 1   NCT04630873   Greece
HC-58
   Asahi Kasei Pharma Corporation
      2012   Phase 2   NCT01623622   Japan
Humac balance system FOR postural stability evaluation
   Cairo University
      2023   -   NCT06989034   Egypt
Lacosamide
   UCB Japan Co., Ltd.
      2016   Phase 3   JPRN-jRCT2080223050   Asia except Japan;Europe;Japan;North America;Oceania
Levetiracetam
   UCB Japan Co., Ltd.
      2017   Phase 3   JPRN-jRCT2080223815   Japan
Measurement OF multifidus and gastrocnemius muscle thickness with ultrasound
   Uskudar State Hospital
      2023   -   NCT05871723   -
Medicinal AIR
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 3   NCT00632528   France
Melatonin
   Hospices Civils de Lyon
      2019   -   NCT04020848   France
Meopa
   Assistance Publique - Hôpitaux de Paris
      2008   Phase 3   NCT00632528   France
Nociceptor flexor reflex
   Mustafa Kemal University
      2018   Phase 4   NCT03860662   Turkey
Onabotulinumtoxina FOR injection
   Konya Beyhekim Training and Research Hospital
      2022   Phase 4   NCT05615987   Turkey
Oxygen
   Assistance Publique - Hôpitaux de Paris
      2024   Phase 2   NCT06248645   France
   Changzhou De'an Hospital
      2026   -   ChiCTR2500115588   China
   The First Affiliated Hospital of Bengbu Medical College
      2022   Phase 0   ChiCTR2200065699   China
Padsevonil
   UCB Japan Co., Ltd.
      2019   Phase 1   JPRN-jRCT2080224874   Japan
      2019   Phase 3   JPRN-jRCT2080224661   Asia except Japan;Europe;Japan;North America;Oceania
      2019   Phase 2-3   JPRN-jRCT2080224540   Europe;Japan;North America;Oceania
      2018   Phase 2   JPRN-jRCT2080224509   Europe;Japan;North America
Psilocybin
   Johns Hopkins University
      2026   Phase 1   NCT07053917   United States
Reactive balance training
   Cairo University
      2025   -   NCT07401108   Egypt
Selective motor control evaluation FOR THE upper and lower extremities
   Cairo University
      2023   -   NCT06989034   Egypt
Sham mirror therapy
   Fatih Sultan Mehmet Training and Research Hospital
      2024   -   NCT07331844   Turkey (Türkiye)
Sodium oxybate
   University of Utah
      2009   Phase 1/Phase 2   NCT00931164   United States
Standard medical treatment
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
THE patients' parents have TO complete THE vineland II adaptive behavior scales scoring, THE sleep disturbance scale FOR children (sdsc) and horne & ostberg circadian typology questionnaire
   Hospices Civils de Lyon
      2019   -   NCT04020848   France
THE selected physical therapy program
   Cairo University
      2025   -   NCT07648550   Egypt
Time delay treatment OF botulinum toxin
   University Hospital, Clermont-Ferrand
      2005   Phase 3   NCT00276185   France
Tocilizumab
   Beijing Childrens Hospital,Capital Medical University
      2026   -   ChiCTR2600126257   China
   Peking University First Hospital
      2024   Phase 4   ChiCTR2400085185   China
   Yale University
      2026   Phase 3   NCT07281027   Canada;France;Italy;South Korea;Sweden;United Kingdom;United States
Triheptanoin
   Institut National de la Santé Et de la Recherche Médicale, France
      2015   Phase 2   NCT02408354   France
Ultrasound-guided suprascapular nerve block
   Abant Izzet Baysal University
      2022   Phase 4   NCT05260125   Turkey
Upper limb muscle block
   Centre d'Investigation Clinique et Technologique 805
      2015   -   NCT02455232   France
Virtual balance training
   Abant Izzet Baysal University
      2021   -   NCT05552742   Turkey
Virtual reality
   Cairo University
      2025   -   NCT07401108   Egypt
Whole exome sequencing
   Institute of Child Health
      2018   -   NCT03857607   United Kingdom